Pharmacokinetic–pharmacodynamic model for propofol for broad application in anaesthesia and sedation

[1]  M. Kleiber.  Body size and metabolism , 1932 .

[2]  H Schwilden,et al.  Total intravenous anaesthesia with propofol and alfentanil by computer‐assisted infusion , 1988, Anaesthesia.

[3]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[4]  R. Farinotti,et al.  Propofol Infusion for Maintenance of Anesthesia in Morbidly Obese Patients Receiving Nitrous Oxide A Clinical and Pharmacokinetic Study , 1993, Anesthesiology.

[5]  T. Short,et al.  A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients. , 1994, British journal of anaesthesia.

[6]  H F Nicodemus,et al.  The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches , 1994, Anesthesiology.

[7]  Nicholas H. G. Holford,et al.  A Size Standard for Pharmacokinetics , 1996, Clinical pharmacokinetics.

[8]  James H. Brown,et al.  A General Model for the Origin of Allometric Scaling Laws in Biology , 1997, Science.

[9]  S. Shafer,et al.  The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.

[10]  J. Glen,et al.  The development of ‘Diprifusor’: a TCI system for propofol , 1998, Anaesthesia.

[11]  N. Holford,et al.  Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. , 1998, British journal of clinical pharmacology.

[12]  M. Priston,et al.  Pharmacokinetics of Propofol Infusions in Critically Ill Neonates, Infants, and Children in an Intensive Care Unit , 2002, Anesthesiology.

[13]  M. White,et al.  Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. , 2003, British journal of anaesthesia.

[14]  Lewis B. Sheiner,et al.  Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[15]  J. Bruhn,et al.  Pharmacodynamic Interaction between Propofol and Remifentanil Regarding Hypnosis, Tolerance of Laryngoscopy, Bispectral Index, and Electroencephalographic Approximate Entropy , 2004, Anesthesiology.

[16]  Anthony G. Doufas,et al.  Induction Speed Is Not a Determinant of Propofol Pharmacodynamics , 2004, Anesthesiology.

[17]  Lewis B. Sheiner,et al.  Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[18]  G. Kenny,et al.  'Paedfusor' pharmacokinetic data set. , 2005, British journal of anaesthesia.

[19]  Steven L. Shafer,et al.  Measuring the predictive performance of computer-controlled infusion pumps , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[20]  R. Sethuraman.  Chapter 133 – Intravenous Drug Delivery Systems , 2007 .

[21]  Talmage D Egan,et al.  When Is a Bispectral Index of 60 Too Low?: Rational Processed Electroencephalographic Targets Are Dependent on the Sedative–Opioid Ratio , 2007, Anesthesiology.

[22]  I. Murat,et al.  Maturational pharmacokinetics of single intravenous bolus of propofol , 2007, Paediatric anaesthesia.

[23]  Paediatric propofol pharmacokinetics: a multicentre study , 2007 .

[24]  N. Holford,et al.  Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.

[25]  M. White,et al.  Use of Target Controlled Infusion to Derive Age and Gender Covariates for Propofol Clearance , 2008, Clinical pharmacokinetics.

[26]  M. Avram,et al.  Early Drug Distribution: A Generally Neglected Aspect of Pharmacokinetics of Particular Relevance to Intravenously Administered Anesthetic Agents , 2008, Clinical pharmacology and therapeutics.

[27]  Mats Enlund,et al.  TCI : Target Controlled Infusion, or Totally Confused Infusion? Call for an Optimised Population Based Pharmacokinetic Model for Propofol. , 2008, Upsala journal of medical sciences.

[28]  M. Struys,et al.  Pharmacokinetic models for propofol--defining and illuminating the devil in the detail. , 2009, British journal of anaesthesia.

[29]  A. Dahan,et al.  Mixed-Effects Modeling of the Influence of Midazolam on Propofol Pharmacokinetics , 2009, Anesthesia and analgesia.

[30]  N. Holford,et al.  Mechanistic basis of using body size and maturation to predict clearance in humans. , 2009, Drug metabolism and pharmacokinetics.

[31]  M. Struys,et al.  The Performance of Compartmental and Physiologically Based Recirculatory Pharmacokinetic Models for Propofol: A Comparison Using Bolus, Continuous, and Target-Controlled Infusion Data , 2010, Anesthesia and analgesia.

[32]  M. Struys,et al.  Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. , 2010, British journal of anaesthesia.

[33]  M. Struys,et al.  Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts. , 2011, British journal of anaesthesia.

[34]  Hugo Vereecke,et al.  An Evaluation of Using Population Pharmacokinetic Models to Estimate Pharmacodynamic Parameters for Propofol and Bispectral Index in Children , 2011, Anesthesiology.

[35]  D. Eleveld,et al.  Performance of Propofol Target-Controlled Infusion Models in the Obese: Pharmacokinetic and Pharmacodynamic Analysis , 2014, Anesthesia and analgesia.

[36]  Michel M. R. F. Struys,et al.  A General Purpose Pharmacokinetic Model for Propofol , 2014, Anesthesia and analgesia.

[37]  C. Pichard,et al.  Body composition during growth in children: limitations and perspectives of bioelectrical impedance analysis , 2015, European Journal of Clinical Nutrition.

[38]  Hesham S. Al-Sallami,et al.  Prediction of Fat-Free Mass in Children , 2015, Clinical Pharmacokinetics.

[39]  T. Inge,et al.  Population pharmacokinetic–pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents , 2015, Paediatric anaesthesia.

[40]  Thomas W. Schnider,et al.  The History of Target-Controlled Infusion , 2016, Anesthesia and analgesia.

[41]  Michel M R F Struys,et al.  Target-Controlled Infusion: A Mature Technology , 2016, Anesthesia and analgesia.

[42]  T. Bouillon,et al.  Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil. , 2016, British journal of anaesthesia.

[43]  S. Shafer,et al.  Allometry, Shallometry! , 2016, Anesthesia and analgesia.

[44]  Tae Kyun Kim,et al.  Disposition of Remifentanil in Obesity: A New Pharmacokinetic Model Incorporating the Influence of Body Mass , 2017, Anesthesiology.

[45]  M. Struys,et al.  An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics , 2017, Anesthesiology.